ArticleOrphanet journal of rare diseases2026
In vitro characterization of osteoblasts from craniofacial fibrous dysplasia of bone and their impact on bone homeostasis.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrous Dysplasia (FD) is a benign and rare genetic disease characterized by progressive replacement of normal bone by a non-mineralized matrix. FD is caused by GNAS mutations that increase intracellular cAMP levels. While appendicular lesions have been extensively studied to enhance understanding and management of the disease, the pathogenesis of craniofacial lesions remains poorly described despite the embryological, phenotypic and mechanical differences between these two skeletal regions. Our objective was to evaluate the impact of craniofacial FD on bone homeostasis. Typical histological features, suh as “alphabet soup” appearance, were observed in craniofacial FD lesions. Higher intracellular cAMP levels were also noted in FD cultures derived from craniofacial lesions. We demonstrated an increased proliferative capacity in craniofacial FD osteoblasts, associated with decreased osteoblastic differentiation and a lack in mineralization abilities. Interestingly, we highlighted a decreased osteoclastogenic potential due to impaired osteoclast formation in FD-conditioned medium cultures, indicating a diminished osteoclastogenic potential of craniofacial FD osteoblasts. Our data suggest shared characteristics between osteoblasts from the craniofacial and the appendicular skeletons but also discrepancies regarding osteoclastic potential. Exploring these features could help explain the differences observed between appendicular and cranio-facial lesions and should lead to further studies on the pathogenesis of craniofacial fibrous dysplasia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.